T 1117/23 of 08.08.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T111723.20240808
- Date of decision
- 8 August 2024
- Case number
- T 1117/23
- Online on
- 14 August 2024
- Petition for review of
- -
- Application number
- 17187458.9
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- ANTI-ANDROGENS FOR THE TREATMENT OF NON-METASTATIC CASTRATE-RESISTANT PROSTATE CANCER
- Applicant name
- Aragon Pharmaceuticals, Inc.
- Opponent name
- Sandoz AG
Teva Pharmaceutical Industries Ltd
Synthon BV - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 108European Patent Convention R 99(2)European Patent Convention R 101(1)
- Keywords
- Admissibility of appeal - missing statement of grounds
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is rejected as inadmissible.